Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 7157923, 8 pages
https://doi.org/10.1155/2017/7157923
Research Article

Integron-Mediated Antibiotic Resistance in Acinetobacter baumannii Isolated from Intensive Care Unit Patients, Babol, North of Iran

1Department of Microbiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
2Department of Medical Biotechnology, Faculty of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran
3Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran
4Department of Biostatistics and Epidemiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
5Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Correspondence should be addressed to Ramazan Rajabnia; moc.oohay@96nazamar

Received 6 December 2016; Revised 12 February 2017; Accepted 27 February 2017; Published 19 July 2017

Academic Editor: Paul M. Tulkens

Copyright © 2017 Mitra Deylam Salehi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. K. Sahu, P. S. Iyer, S. H. Barage, K. D. Sonawane, and B. A. Chopade, “Characterization of the algC gene expression pattern in the multidrug resistant Acinetobacter baumannii AIIMS 7 and correlation with biofilm development on abiotic surface,” Scientific World Journal, vol. 2014, Article ID 593546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. E. Karageorgopoulos and M. E. Falagas, “Current control and treatment of multidrug-resistant Acinetobacter baumannii infections,” The Lancet Infectious Diseases, vol. 8, no. 12, pp. 751–762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Manchanda, S. Sanchaita, and N. P. Singh, “Multidrug resistant acinetobacter,” Journal of Global Infectious Diseases, vol. 2, no. 3, pp. 291–304, 2010. View at Publisher · View at Google Scholar
  4. R. A. Bonomo and D. Szabo, “Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa,” Clinical Infectious Diseases, vol. 43, supplement 2, pp. S49–S56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Z. Bialvaei, H. S. Kafil, M. Asgharzadeh, M. Aghazadeh, and M. Yousefi, “CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals,” Brazilian Journal of Microbiology, vol. 47, no. 3, pp. 706–711, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Taherikalani, A. Maleki, N. Sadeghifard et al., “Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran,” Polish Journal of Microbiology, vol. 60, no. 2, pp. 169–174, 2011. View at Google Scholar · View at Scopus
  7. Y. Zhu, Y. Yi, F. Liu et al., “Distribution and molecular profiling of class 1 integrons in MDR Acinetobacter baumannii isolates and whole genome-based analysis of antibiotic resistance mechanisms in a representative strain,” Microbiological Research, vol. 169, no. 11, pp. 811–816, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Moradian Kouchaksaraei, E. Ferdosi Shahandashti, Z. Molana et al., “Molecular detection of integron genes and pattern of antibiotic resistance in pseudomonas aeruginosa strains isolated from intensive care unit, Shahid Beheshti hospital, North of Iran,” International Journal of Molecular and Cellular Medicine, vol. 1, no. 4, pp. 209–217, 2012. View at Google Scholar
  9. F. Ahangarkani, R. Rajabnia, E. Shahandashti, M. Bagheri, and M. Ramez, “Frequency of class 1 integron in Escherichia coli strains isolated from patients with urinary tract infections in North of Iran,” Mater Sociomed, vol. 27, no. 1, pp. 10–12, 2015. View at Publisher · View at Google Scholar
  10. C. Goldstein, M. D. Lee, S. Sanchez et al., “Incidence of class 1 and 2 integrases in clinical and commensal bacteria from livestock, companion animals, and exotics,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 3, pp. 723–726, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Deylam Salehi, E. Ferdosi-Shahandashti, Y. Yahyapour, S. Khafri, A. Pournajaf, and R. Rajabnia, Molecular study ofintegrons class I, II, III and its relation to antibiotic resistance inAcintobacter strains isolated from patients in intensive care hospital Rohani Babol. [A thesis for MSc dissertation], Babol University of medical sciences, Babol, Iran, 2016.
  12. J. C. P. Gomes, W. L. Pedreira, E. M. P. A. Araújo et al., “Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy,” Clinical Investigations in Critical Care, vol. 118, no. 6, pp. 1739–1746, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. C. R. Zaccard, R. F. Schell, and C. A. Spiegel, “Efficacy of bilateral bronchoalveolar lavage for diagnosis of ventilator-associated pneumonia,” Journal of Clinical Microbiology, vol. 47, no. 9, pp. 2918–2924, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Vakili, H. Fazeli, P. Shoaei et al., “Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran,” Journal of Research in Medical Sciences, vol. 19, pp. S67–S70, 2014. View at Google Scholar · View at Scopus
  15. P. G. Higgins, H. Wisplinghoff, O. Krut, and H. Seifert, “A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU,” Clinical Microbiology and Infection, vol. 13, no. 12, pp. 1199–1201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Kamolvit, P. G. Higgins, D. L. Paterson, and H. Seifert, “Multiplex PCR to detect the genes encoding naturally occurring oxacillinases in Acinetobacter spp,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 4, Article ID dkt480, pp. 959–963, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. “Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement,” Clinical and Laboratory Standards Institute, vol. 35, no. 3, pp. 44–50, 2015.
  18. F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo, “Global challenge of multidrug-resistant Acinetobacter baumanni,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 10, pp. 3471–3484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Nomanpour, A. Ghodousi, A. Babaei, H. Abtahi, M. Tabrizi, and M. M. Feizabadi, “Rapid, cost-effective, sensitive and quantitative detection of Acinetobacter baumannii from pneumonia patients,” Iranian Journal of Microbiology, vol. 3, no. 4, pp. 162–169, 2011. View at Google Scholar · View at Scopus
  20. H. Ghajavand, B. N. Esfahani, S. A. Havaei, S. Moghim, and H. Fazeli, “Molecular identification of Acinetobacterbaumannii isolated from intensive care units and their antimicrobial resistance patterns,” Advanced Biomedical Research, vol. 4, no. 110, 2015. View at Google Scholar
  21. M.-C. Chan, S.-K. Chiu, P.-R. Hsueh, N.-C. Wang, C.-C. Wang, and C.-T. Fang, “Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control study,” PLoS ONE, vol. 9, no. 1, article e85973, 2014. View at Google Scholar · View at Scopus
  22. M. S. Ramírez, M. S. Stietz, E. Vilacoba et al., “Increasing frequency of class 1 and 2 integrons in multidrug-resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance,” International Journal of Antimicrobial Agents, vol. 37, no. 2, pp. 175–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Kamalbeik, H. Talaie, A. Mahdavinejad, A. Karimi, and A. Salimi, “Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: is there an association?” Korean Journal of Anesthesiology, vol. 66, no. 4, pp. 295–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Ramírez, A. Morales, E. Vilacoba, C. Márquez, and D. Centrón, “Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii,” Current Microbiology, vol. 64, no. 3, pp. 290–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Martins, R. C. Picão, S. Adams-Sapper, L. W. Riley, and B. M. Moreira, “Association of class 1 and 2 integrons with multidrug-resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 1, pp. 698–701, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Taherikalani, A. Maleki, N. Sadeghifars, D. Mohammadzadeh, P. Asadollahi, and M. Emaneini, “Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran,” Polish Journal of Microbiology, vol. 60, no. 2, pp. 169–174, 2011. View at Google Scholar · View at Scopus
  27. F. Moammadi, M. Arabestani, M. Safari, G. Roshanaii, and M. Alikhani, “Prevalence of class 1, 2 and 3 integrons among extensive drug resistance Acinetobacter baumanii strains isolated from intensive care units in Hamadan, west province,” Iranian Journal of Medical Microbiology, vol. 8, no. 3, pp. 8–14, 2014. View at Google Scholar
  28. M. F. Lin, K. C. Chang, C. Y. Yang et al., “Role of integrons in antimicrobial susceptibility patterns of Acinetobacter baumannii,” Japanese Journal of Infectious Diseases, vol. 63, pp. 440–443, 2010. View at Google Scholar
  29. R. Mirnejad, S. Mostofi, and F. Masjedian, “Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 2, pp. 140–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. M. Koeleman, J. Stoof, M. W. Van der Bijl, C. M. J. E. Vandenbroucke-Grauls, and P. H. M. Savelkoul, “Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR,” Journal of Clinical Microbiology, vol. 39, no. 1, pp. 8–13, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Gaur, P. Prakash, S. Anupurba, and T. M. Mohapatra, “Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multidrug-resistant Acinetobacter baumannii isolated from nosocomial infections,” International Journal of Antimicrobial Agents, vol. 29, no. 4, pp. 446–450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. L. Maragakis and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008. View at Publisher · View at Google Scholar · View at Scopus